School-based Treatment of Anxiety Research Study (STARS) (STARS)

January 7, 2019 updated by: Golda S. Ginsburg, UConn Health

Modular CBT for Reducing Anxiety and Improving Educational Outcomes

This research is being done to compare two types of talk therapy to see which is most effective in helping school children with anxiety disorders. The investigators will compare usual care (UC) with cognitive behavioral therapy (CBT). Both therapies will be administered by the school mental health counselors to see if they help children with anxiety disorders to feel less scared or worried.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This four year study involves a blocked randomized controlled trial (RCT) comparing the effectiveness of school-based CBT to usual care (UC) for approximately 375 students ages 7-17 diagnosed with an anxiety disorder. Randomization will occur at the school level and the investigators propose to conduct the study in approximately 46 schools (23 in CBT; 23 UC). Evaluations will be conducted by study staff to measure treatment progress at the end of the 12-week treatment program, at a three month follows up, and at natural termination.

Study Type

Interventional

Enrollment (Actual)

216

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • Farmington, Connecticut, United States, 06030
        • University of Connecticut Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • between the ages of 6-18 inclusively
  • meet DSM-IV criteria for a primary anxiety disorder

Exclusion Criteria:

  • presence of a medical or psychiatric condition contraindicating study treatment (e.g., suicidal intent)
  • need more immediate or alternative treatment
  • receiving psychosocial treatment for anxiety
  • victim of previously undisclosed child abuse and require ongoing Department of Children and Families (DCF) supervision

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBT
Cognitive behavioral therapy
Other Names:
  • Cognitive Behavioral therapy
Active Comparator: UC
Usual care
Other Names:
  • Usual Care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Global Impressions Improvement Scale
Time Frame: 12 weeks post-treatment
Improvement in Clinical Anxiety Diagnosis
12 weeks post-treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
School Records
Time Frame: 12 weeks post-treatment
Academic functioning
12 weeks post-treatment
Teacher Report Form
Time Frame: 12 weeks post-treatment
classroom behavior and performance
12 weeks post-treatment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Screen for Child Anxiety Related Emotional Disorders
Time Frame: 12 weeks post-treatment
Additional measures of symptoms, mediators, and moderators
12 weeks post-treatment
Children's Automatic Thoughts Scale
Time Frame: 12 weeks post-treatment
Cognitive distortions related to anxiety
12 weeks post-treatment
Woodcock-Johnson Tests of Achievement
Time Frame: 12 weeks post-treatment
Academic achievement and working memory
12 weeks post-treatment
Children's Global Assessment Scale
Time Frame: 12 weeks post-treatment
Global Functioning
12 weeks post-treatment
Brief Symptom Inventory
Time Frame: 12 weeks post-treatment
Parental psychopathology
12 weeks post-treatment
The TCU Organizational Readiness to Change
Time Frame: 12 weeks post-treatment
Clinician's perceptions of workplace attributes
12 weeks post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Golda S Ginsburg, Ph.D., University of Connecticut

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2012

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

June 30, 2018

Study Registration Dates

First Submitted

October 12, 2012

First Submitted That Met QC Criteria

January 3, 2013

First Posted (Estimate)

January 4, 2013

Study Record Updates

Last Update Posted (Actual)

January 8, 2019

Last Update Submitted That Met QC Criteria

January 7, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NA00075767
  • R324A120405 (Other Grant/Funding Number: Institute of Educational Sciences (IES))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Will follow IES procedures for making de-identified data set available

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety Disorders

Clinical Trials on CBT

Subscribe